Latest news with #QuidelOrthoCorporation
Malaysian Reserve
4 days ago
- Business
- Malaysian Reserve
QuidelOrtho Launches Certified Analyzer Program
Initiative to expand testing access to underserved U.S. communities SAN DIEGO, Aug. 13, 2025 /PRNewswire/ — QuidelOrtho Corporation has launched a Certified Analyzer Program, an innovative initiative designed to expand access to high-quality diagnostic testing in rural and community hospitals across the United States. Tailored for clinics, physician office labs and small hospitals with fewer than 100 beds, the program offers certified VITROS™ analyzers that deliver proven reliability and quality results, with award-winning service, at a fraction of the cost. 'Our mission is rooted in equipping our customers so they can deliver diagnostic excellence to patients,' said Audra Jones, Senior Vice President, North America, QuidelOrtho. 'By repurposing and rigorously certifying high-performing analyzers, we aim to expand access to reliable diagnostic technology for healthcare facilities that play a critical role in their communities.' Each analyzer in the program undergoes a robust, multi-point certification process at QuidelOrtho's Rochester facility, including over 140 system checks, functional adjustments, hardware cleaning or replacement, and extensive performance testing. These analyzers undergo a comprehensive certification process to align with QuidelOrtho's established quality and performance criteria and include a 12-month warranty on service and support. The program features certified VITROS XT 7600 and 5600 Integrated Systems and the VITROS 3600 Immunodiagnostic System. The VITROS platforms are designed to support community labs running general chemistries, immunoassay tests and drugs of abuse screening. 'We're proud to support healthcare providers who are the backbone of their communities, backed by our award-winning service and top-ranked customer satisfaction,' added Jones. 'This program isn't just about affordability; it's designed to improve accessibility and access of diagnostic solutions for healthcare providers in underserved communities.' QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit and follow QuidelOrtho on LinkedIn, Facebook and X. About QuidelOrtho Corporation QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day. Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed–from home to hospital, lab to clinic. Building on its long history of innovation, QuidelOrtho works with global healthcare customers to advance diagnostics, where insights and solutions seamlessly connect, illuminating a clearer path for informed decisions. Investor Contact: Juliet Cunningham Vice President, Investor Relations IR@ Media Contact: D. Nikki Wheeler Senior Director, Corporate Communications Media@
Yahoo
29-07-2025
- Business
- Yahoo
QuidelOrtho Recognized with Three Awards in 2025 IMV ServiceTrak™
SAN DIEGO, July 29, 2025 /PRNewswire/ -- QuidelOrtho earned three awards and top rankings in the 2025 IMV ServiceTrak™ Awards, presented at the Association for Diagnostics & Laboratory Medicine, recognizing excellence in customer satisfaction across key performance areas. Awards: Chemistry Best overall system performance Integrated Systems Best overall system performance Best overall service Top Rankings: QuidelOrtho received top rankings in several key categories for Integrated Systems, including: #1 Overall Net Promoter Score (NPS) by Manufacturer #1 Overall Manufacturer Performance #1 Overall Service Engineer Performance #1 Overall Training Performance QuidelOrtho invested in initiatives focused on what customers value most, driving significant advances in reliability, product quality and service. This commitment delivered a 17-point increase in NPS, the largest gain in the category, reflecting higher customer loyalty and satisfaction. Learn how QuidelOrtho prioritizes customers' beliefs and values to deliver solutions. These awards and rankings showcase QuidelOrtho's comprehensive approach to enhancing both product and service in clinical diagnostics. A key part of this success has been investing in employee development through specialized customer experience training, fueling continued progress and stronger relationships with customers. QuidelOrtho remains committed to ongoing innovation and delivering smart, customer-focused solutions that elevate laboratory efficiency and outcomes. Key Quotes: Karen Taylor, Senior Vice President, Customer Experience, QuidelOrtho "We're honored to be recognized with three awards and top rankings in this year's IMV ServiceTrak Awards, but even more so, we're grateful to our customers for their ongoing trust and collaboration. These results reflect their feedback and our shared commitment to improving outcomes together. Our QuidelOrthoCQ™ solutions are designed to give customers the freedom to focus on what matters most. We'll continue listening and evolving to better support their success." Additional Resources: Listen to Karen Taylor's Repertoire Magazine Interview: Freedom to Focus: How QuidelOrthoCQ is creating delightful customer experiences About IMV ServiceTrakThe IMV ServiceTrak Clinical Laboratory Awards are the result of independent market research assessing manufacturer performance in the in-vitro diagnostics space. IMV's annual report represents an independent analysis of customer satisfaction with instrument manufacturers, system performance and service received. IMV's ServiceTrak Clinical Laboratory Awards are based on feedback from laboratory testing professionals in 1,800 clinical testing locations, representing 4,100 instruments. For over 25 years, IMV ServiceTrak has provided independent analysis of service trends and manufacturer ratings in laboratory diagnostics. About QuidelOrtho Corporation QuidelOrtho Corporation (Nasdaq: QDEL) is a global provider of innovative diagnostic testing solutions. From infectious diseases to cardiac biomarkers to women's health, QuidelOrtho transforms the power of diagnostics into a healthier future through science, innovation and accessibility. Learn more at Investor Contact: Media Contact: Juliet Cunningham D. Nikki Wheeler Vice President, Investor Relations Senior Director, Corporate IR@ CommunicationsMedia@ View original content to download multimedia: SOURCE QuidelOrtho Corporation
